Epidemiology of hepatitis C in the west

Seminars in Liver Disease

Volumn 15, Issue 1, 1995, Pages 5-14

  Alter, Miriam J ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE PERSONNEL; HEPATITIS C; HUMAN; INFECTION RISK; MORBIDITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0028898609     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007259     Document Type: Review

References (151)

1. Alter MJ, Margolis HS, Krawczynski K, et al: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905, 1992.
2. Kleinman S, Alter H, Busch M, et al: Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32:805-813, 1992.
3. Mimms L, Vallari D, Ducharme L, et al: Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 336:1590-1591, 1990.
4. Centers for Disease Control: Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 40(RR-4): 1-17, 1991.
5. Chaudhary R, Bact D, Maclean C: Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay. Am J Clin Pathol 99:702-704, 1993.
6. Puro V, Girardi E, Ippolito G, et al: Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol 99:598-600, 1992.
7. Marcellin P, Bernuau J, Martinot-Peignoux M, et al: Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 38:2151-2155, 1993.
8. Roudot-Thoraval F, Pawlotsky J-M, Thiers V, et al: Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 17:722-777, 1993.
9. Esteban JI, Gonzalez A, Hernandez JM, et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112, 1990.
10. Alter HJ, Jett BW, Polito AJ, et al: Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Margolis HS (Eds): Viral Hepatitis and Liver Disease. Baltimore, Williams and Wilkins, 1991, pp. 396-402.
11. Alter HJ: Post-transfusion hepatitis in the United States. In: Nishioka K, Suzuki H, Mishiro S, Oda T (Eds): Viral Hepatitis and Liver Disease. Tokyo, Springer-Verlag, 1994, pp. 551-553.
12. Aach RD, Stevens CE, Hollinger FB, et al: Hepatitis C virus infection in post-transfusion hepatitis. An analysis with firstand second-generation assays. N Engl J Med 325:1325-1329, 1991.
13. Koretz RL, Brezina M, Polito AJ, et al: Non-A, non-B post-transfusion hepatitis: Comparing C and non-C hepatitis. Hepatology 17:361-365, 1993.
14. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 114:277-281, 1991.
15. Berrera JM, Brugera M, Guadalupe E, et al: Incidence of non-A, non-B hepatitis after screening blood donors for antibodies for hepatitis C virus and surrogate markers. Ann Intern Med 115:596-600, 1991.
16. Elia GF, Magnani G, Belli L, et al: Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy. Infection 19:336-339, 1991.
17. Mattsson L, Grillner L, von Sydow M, et al: Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 19:309-312, 1991.
18. Goncales FL, Jr, Pedro R de J, Da Silva LJ, et al: Post-transfusional hepatitis in the city of Campinas SP, Brazil. I. Incidence, etiological agents and clinico-epidemiological aspects of hepatitis C. Revista do Institute de Medicina Tropical de Sao Paulo 35:53-62, 1993.
19. Jullien AM, Courouce AM, Massari V, et al: Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 12:668-672, 1993.
20. Donahue JG, Munoz A, Ness PM, et al: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373, 1992.
21. Nelson KE, Ahmed F, Ness P, et al: Comparison of first and second generation ELISA screening tests in detecting HCV infections in transfused cardiac surgery patients [abstract]. Program and Abstracts of the International Symposium on Viral Hepatitis and Liver Disease, 1993, p. 50.
22. Alter MJ, Hadler SC, Judson FN, et al: Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264:2231-2235, 1990.
23. Bortolotti F, Tagger A, Cadrobbi P, et al: Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. J Hepatol 12:176-180, 1991.
24. Tassopoulos NC, Hatzakis A, Delladetsima I, et al: Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A 5-year prospective study. Gastroenterology 102:969-972, 1992.
25. Rodriguez M, Riestra S, San Roman F, et al: Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories. Liver 11:129-133, 1991.
26. Krogsgaard K, Wantzin P, Mathiesen LR, et al: Early appearance of antibodies to hepatitis C virus in community acquired acute non-A, non-B hepatitis is associated with progression to chronic liver disease. Scand J Infect Dis 22:399-402, 1990.
27. Laskus T, Lupa E, Cianciara J, Slusarczyk J: Acute non-A, non-B hepatitis in a hospital population in Warsaw, Poland: Clinical and epidemiological aspects. Am J Gastroenterol 86:565-569, 1991.
28. Alter MJ: The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 2:155-166, 1993.
29. Alter MJ, Coleman PJ, Alexander WJ, et al: Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 262:1201-1205, 1989.
30. Van Ameijden EJC, Van den Hoek JAR, Mientjes GHC, Coutinho RA: A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 9:255-262, 1993.
31. Vlahov D, Nelson KE, Quinn TC, Kendig N: Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 9:566-569, 1993.
32. Niu MT, Coleman PJ, Alter MJ: Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and staff. Am J Kidney Dis 1993; 22:568-573, 1993.
33. Jadoul M, Cornu C, Van Ypersele de Strihou C, UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322-1326, 1993.
34. Centers for Disease Control: Hepatitis Surveillance Report No. 55, CDC, Atlanta, 1994.
35. Pereira BJG, Milford EL, Kirkman RL, et al: Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 327:910-915, 1992.
36. Roth D, Fernandez JA, Babischkin S, et al: Detection of hepatitis C virus infection among cadaver organ donors: Evidence for low transmission of disease. Ann Intern Med 117:470-475, 1992.
37. Esteban JI, Esteban R, Viladomiu L, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294-296, 1989.
38. Rumi MG, Colombo M, Gringeri A, Mannucci PM: High prevalence of antibody to hepatitis C virus in multitransfused haemophilacs with normal transaminase levels. Ann Intern Med 112:379-380, 1990.
39. Troisi CL, Hollinger FB, Hoots WK, et al: A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81:412-418, 1993.
40. Hadziyannis SJ, Giannoulis G, Hadziyannis E, et al: Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatology 17(suppl. 3):S72-S77, 1993.
41. Hyams KC, Phillips IA, Moran AY, et al: Seroprevalence of hepatitis C antibody in Peru. J Med Virol 37:127-131, 1992.
42. Rollag H, Evesen SA, Froland SS, Glomstein A: Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools. Eur J Clin Microbiol Infect Dis 9:612-614, 1990.
43. Donahue JG, Nelson KE, Munoz A, et al: Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 134:1206-1211, 1991.
44. Zeldis JB, Jain S, Kuramoto IK, et al: Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med 156:30-35, 1992.
45. Van den Hoek JAR, Van Haastrecht HJA, Goudsmit J, et al: Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 160:823-826, 1990.
46. Alter MJ, Gerety RJ, Smallwood L, et al: Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban United States population. J Infect Dis 145:886-893, 1982.
47. Thomas DL, Factor SH, Kelen GD, et al: Viral hepatitis in health care personnel at The Johns Hopkins Hospital. Arch Intern Med 153:1705-1712, 1993.
48. Polish LB, Tong MJ, Co RL, et al: Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 21:196-200, 1993.
49. Cooper BW, Krusell A, Tilton RC, et al: Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 13:82-85, 1992.
50. Mortimer PP, Cohen BJ, Litton PA, et al: Hepatitis C virus antibody. Lancet 2:798, 1989.
51. Germanaud J, Barthez JP, Causse X: The occupational risk of hepatitis C infection among hospital employees. Am J Pub Health 84:122, 1994.
52. Campello C, Majori S, Poli A, et al: Prevalence of HCV antibodies in health-care workers from northern Italy. Infection 20:224-226, 1992.
53. 3. Soni PN, Tait DR, Kenoyer DG, et al: Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 40:65-68, 1993.
54. Klein RS, Freeman K, Taylor PE, Stevens CE: Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 338:1539-1542, 1991.
55. Seeff LB: Hepatitis C from a needlestick injury. Ann Intern Med 115:411, 1991.
56. Marranconi F, Mecenero v, Pellizzer GP, et al: HCV infection after accidental needlestick injury in health-care workers. Infection 20:111, 1992.
57. Cariani E, Zonaro A, Primi D, et al: Detection of HCV RNA and antibodies to HCV after needlestick injury. Lancet 337:850, 1991.
58. Schlipkoter U, Roggendorf M, Cholmakow K, et al: Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand J Infect Dis 22:757-758, 1990.
59. Sartori M, La Terra G, Aglietta M, et al: Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 25:270-271, 1993.
60. Francavilla E, Rinaldi R, Cattelan AM, et al: Low prevalence of antibodies to hepatitis C virus in hospital employees. Infection 20:295, 1992.
61. Lanphear BP, Linnemann CC, Cannon CG, et al: Hepatitis C virus infection in health care workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 15:745-750, 1994.
62. Louie M, Low DE, Feinman SV, et al: Prevalence of blood-borne infective agents among people admitted to a Canadian hospital. Can Med Assoc J 146:1331-1334, 1992.
63. Kelen GD, Green GB, Purcell RH, et al: Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 326:1399-1404, 1992.
64. Barham WB, Figueroa R, Phillips IA, Hyams KC: Chronic liver disease in Peru: Role of viral hepatitis. J Med Virol 42:129-132, 1994.
65. Frommel D, Tekle-Haimanot R, Berhe N, et al: A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 49:435-439, 1993.
66. Bile K, Aden C, Norder H, et al: Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia. Scand J Infect Dis 25:559-564, 1993.
67. Tassopoulos NC, Hatzakis A, Vassilopoulou-Kada H, et al: Hepatitis C virus is associated with hospital epidemic of acute non-a, non-B hepatitis [abstract]. Program and Abstracts of the 1990 International Symposium on Viral Hepatitis and Liver Disease, Houston, 1990, p. 155.
68. Brind AM, Codd AA, Cohen BJ, et al: Low prevalence of antibody to hepatitis C virus in north east England. J Med Virol 32:243-248, 1990.
69. Conlon PJ, Walshe JJ, Smyth EG, et al: Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland. Irish J Med Sci 162:145-147, 1993.
70. Bukh J, Wantzin P, Krogsgaard K, et al: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 168:1343-1348, 1993.
71. Kolho E, Oksanen K, Honkanen E, et al: Hepatitis C antibodies in dialysis patients and patients with leukaemia. J Med Virol 40:318-321, 1993.
72. Nordenfelt E, Lofgren B, Widell A, et al: Hepatitis C virus infection in hemodialysis patients in Southern Sweden: Epidemiological, clinical, and diagnostic aspects. J Med Virol 40:266-270, 1993.
73. Medin C, Allander T, Roll M, et al: Seroconversion to hepatitis C virus in dialysis patients: A retrospective and prospective study. Nephron 65:40-45, 1993.
74. Almroth G, Ekermo B, Franzen L, Hed J: Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients. Nephron 59:232-235, 1991.
75. Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 38:44-48, 1992.
76. Zeldis JB, Depner TA, Kuramoto IK, et al: The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 112:958-960, 1990.
77. Jeffers LJ, Ferez GO, DeMedina MD, et al: Hepatitis C infection in two urban hemodialysis units. Kidney Int 38:320-322, 1990.
78. Forseter G, Wormser GP, Adler S, et al: Hepatitis C in the health care setting. Seroprevalence among hemodialysis staff and patients in suburban New York City. AJIC 21:5-8, 1993.
79. Kallinowski B, Theilmann L, Gmelin K, et al: Prevalence of antibodies to hepatitis C virus in hemodialysis patients. Nephron 59:236-238, 1991.
80. Schlipkoter U, Roggendorf M, Ernst G, et al: Hepatitis C virus antibodies in haemodialysis patients (letter). Lancet 335:1409, 1990.
81. Dussol B, Chicheportiche C, Cantaloube JF, et al: Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients. Am J Kidney Dis 22:574-580, 1993.
82. Selgas R, Martinez-Zapico R, Bajo MA, et al: Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 12:28-30, 1992.
83. Petrosillo N, Puro V, Ippolito G, The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis: Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. Nephorn 64:636-639, 1993.
84. Fabrizi F, Raffaele L, Bacchini G, et al: Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: A study with second-generation assays. Nephrol Dial Transplant 8:744-747, 1993.
85. Picciotto A, Varagona G, Gurreri G, et al: Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients. Nephrol Dial Transplant 8:1115-1117, 1993.
86. Mihaljevic I, Feldbauer J, Delajlija M, Grgicevic D: Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients. Vox Sang 63:236, 1992.
87. Muller GY, Zabaleta ME, Armino A, et al: Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Internat 41:1055-1058, 1992.
88. Par A: Antibody to hepatitis C virus in Hungary. Lancet 336:123, 1990.
89. Hruby Z, Sliwinski J, Molin I, et al: High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland. Nephrol Dial Transplant 8:740-743, 1993.
90. Capsa D, Cernescu S, Constantinescu SN, Cernescu C: HCV Seroprevalence in dialysis patients, their relatives and medical staff. Rev Roum Virol 42:171-175, 1991.
91. Niu MT, Alter MJ, Kristensen C, Margolis HS: Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 4:345-352, 1992.
92. Gerber AR, Englender SJ, Selvey D, et al: An outbreak of non-A, non-B hepatitis associated with the infusion of a commercial factor IX complex during cardiovascular surgery. Vox Sang 58:270-275, 1990.
93. Guyer B, Bradley DW, Bryan JA, Maynard JE: Non-A, non-B hepatitis among participants in a plasmapheresis stimulation program. J Infect Dis 139:634-640, 1979.
94. Shapiro CN, Moyer LA, Lynn MR, et al: An outbreak of non-A, non-B hepatitis in southern Illinois, 1988 to 1989 [abstract]. Program and Abstracts of the Second International Symposium on HCV, Los Angeles, November 8-9 1991, p. 87.
95. Thomas DL, Zenilman JM, Alter HJ, et al: Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted diseases clinics - An analysis of 309 sexual partnerships. J Infect Dis, in press.
96. Osmond DH, Charlebois E, Sheppard HW, et al: Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 167:66-71, 1993.
97. Buchbinder SP, Katz MH, Hessol NA, et al: Hepatitis C virus infection in sexually active homosexual men. J Infect 29:263-269, 1994.
98. Corona R, Prignano G, Mele A, et al: Heterosexual and homosexual transmission of hepatitis C virus: Relation with hepatitis B virus and human immunodeficiency virus type I. Epidemiol Infect 107:667-672, 1991.
99. Quaranta JF, Delaney SR, Alleman S, et al: Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (Nice SEROCO cohort). J Med Virol 42:29-32, 1994.
100. Gasparini V, Chiaramonte M, Moschen ME, et al: Hepatitis C virus infection in homosexual men: A seroepidemiological study in gay clubs in north-east Italy. Eur J Epidemiol 7:665-669, 1991.
101. Sonnerborg A, Abebe A, Strannegard O: Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection. Infection 18:347-351, 1990.
102. Westh H, Worm AM, Jensen BL, et al: Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 21:115-117, 1993.
103. Weinstock HS, Bolan G, Reingold AL, Polish LB: Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 269:392-394, 1993.
104. Thomas DL, Cannon RO, Shapiro CN, et al: Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 169:990-995, 1994.
105. van Doornum GJJ, Hooykaas C, Cuypers MT, et al: Prevalence of hepatitis C virus infections among heterosexuals with multiple partners. J Med Virol 35:22-27, 1991.
106. Mast EE, Darrow WW, Witte J, et al: Hepatitis C virus infection among prostitutes: Evidence for sexual transmission and protective efficacy of condoms (abstract). Program and Abstracts of the Third International Symposium on HCV, Strasbourg, 1991, p. 95.
107. Gutierrez P, Orduna A, Bratos MA, et al: Prevalence of antihepatitis C virus antibodies in positive FTA-ABS non-drug abusing female prostitutes in Spain. Sex Transm Dis 19:39-40, 1992.
108. Hyams KC, Phillips IA, Tejada A, et al: Three-year incidence study of retroviral and viral hepatitis transmission in a Peruvian prostitute population. J Acquir Immune Defic Syndr 6:1353-1357, 1993.
109. Everhart JE, Di Bisceglie AM, Murray LM, et al: Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 112:544-545, 1990.
110. Pachucki CT, Lentino JR, Schaaff D, et al: Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users. J Infect Dis 164:820-821, 1991.
111. Eyster ME, Alter HJ, Aledort LM, et al: Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 115:764-768, 1991.
112. Brettler DB, Mannucci PM, Gringeri A, et al: The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected males: An international, multicenter study. Blood 80:540-543, 1992.
113. Osmond DH, Padian NS, Sheppard HW, et al: Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 269:361-365, 1993.
114. Gordon SC, Patel AH, Kulesza GW, et al: Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 87:1849-1851, 1992.
115. Bresters D, Mauser-Bunschoten EP, Reesink HW, et al: Sexual transmission of hepatitis C virus. Lancet 342:210-211, 1993.
116. Deny P, Roulot D, Asselot C, et al: Low rate of hepatitis C virus (HCV) transmission within the family. J Hepatol 14:409-410, 1992.
117. Mondello P, Patti S, Vitale MG, et al: Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver-Preliminary results. Infection 20:51-52, 1992.
118. Bellobuono A, Zanella A, Petrini G, et al: Intrafamilial spread of hepatitis C virus. Transfusion 31:475, 1991.
119. Scaraggi FA, Lomuscio S, Perricci A, et al: Intrafamilial and sexual transmission of hepatitis C virus. Lancet 342:1300-1301, 1993.
120. Camarero C, Martos I, Delgado R, et al: Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr 123:98-99, 1993.
121. Bohman VR, Stettler TW, Little BB, et al: Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women. Obstet Gynecol 80:609-613, 1992.
122. MacLean AB, Cameron S, Follett EAC: Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol 100:702-703, 1993.
123. Wejstal R, Anders W, Mansson AS, et al: Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 117:887-890, 1992.
124. Cilia G, Perez-Trallero E, Iturriza M, et al: Maternal-infant transmission of hepatitis C virus infection. Pediatr Infect Dis 11:417, 1992.
125. Lam JPH, McOmish F, Burns SM, et al: Infrequent vertical transmission of hepatitis C virus. J Infect Dis 167:572-576, 1993.
126. Ohio H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 330:744-750, 1994.
127. Lin HH, Kao JH, Hsu HY, et al: Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 169:638-641, 1994.
128. Bow BC, Coote I, Munru H, et al: Confirmation of hepatitis C virus antibody in blood donors. J Med Virol 41:215-220, 1993.
129. Mathiesen UI, Karlsson E, Foberg U, et al: Also with a restrictive transfusion policy, screening with second-generation antihepatitis C virus enzyme-linked immunosorbent assay would have reduced posttransfusion hepatitis C after open-heart surgery. Scand J Gastroenterol 28:581-584, 1993.
130. Nordoy I, Schrumpf E, Elgjo K, et al: Liver disease in antihepatitis C virus-positive Norwegian blood donors. Scand J Gastroenterol 29:77-81, 1994.
131. Ranger S, Martin P, Roussane MC, Denis F: Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France. Gut 34 (2 Suppl):S50-S51, 1993.
132. Gloskowska-Moraczewska Z, Kacperska E, Seyfried H: Evaluation of screening and complementary tests for anti-HCV antibodies. Acta Haematol Pol 24:273-280, 1993.
133. Lai ME, Mazzoleni AP, Farci P, et al: Markers of hepatitis C virus infection in Sardinian blood donors: Relationship with alanine aminotransferase levels. J Med Virol 41:282-288, 1993.
134. Edelenyi-Pinto M, Carvalho AP, Nogueira C, et al: Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Memorias do Instituto Oswaldo Cruz 88:305-307, 1993.
135. Esteban JI, Lopez-Talavera JC, Genesca J, et al: High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 115:443-449, 1991.
136. Serfaty L, Giral P, Elghouzzi MH, et al: Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to R1BA-2 status: A case-control survey. Hepatology 17:183-187, 1993.
137. Katkov WN, Friedman LS, Cody H, et al: Elevated serum alanine aminotransferase levels in blood donors: The contribution of hepatitis C virus. Ann Intern Med 115:882-884, 1991.
138. Delaporte E, Thiers V, Dazza MC, et al: High level of hepatitis C endemicity in Gabon, equatorial Africa. Trans R Soc Trop Med Hyg 87:636-637, 1993.
139. Abdool Karim SS, Tait DR: Hepatitis C viras infection in urban and rural Natal/KwaZulu. SAMJ 83:191-193, 1993.
140. Alberti A, Chemello L, Cavalletto D, et al: Antibody to hepatitis C viras and liver disease in volunteer blood donors. Ann Intern Med 114:1010-1012, 1991.
141. Garson JA, Tedder RS, Briggs M, et al: Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction infectivity. Lancet 335:1419-1422, 1990.
142. Zanetti AR, Tanzi E, Zehender G, et al: Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis. Lancet 336:448, 1990.
143. Brillanti S, Gaiani S, Miglioli M, et al: Persistent hepatitis C viraemia without liver disease. Lancet 341:464-465, 1993.
144. Seeff LB, Buskell-Bales Z, Wright EC, et al: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906-1911, 1992.
145. Seeff LB and the National Heart, Lung, and Blood Institute Study Group: Sequelae of transfusion-associated non-A, non-B (TA-NANB) hepatitis [abstract]. Program and Abstracts of the Fourth International Symposium on HCV, Tokyo, 1993, p. 29.
146. Yu MC, Tong MJ, Coursaget P, et al: Prevalence of hepatitis B and C viral markers in Black and White patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82:1038-1041, 1990.
147. Di Bisceglie AM, Order SE, Klein JL, et al: The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 86:335-338, 1991.
148. Nalpas B, Driss F, Pol S, et al: Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 12:70-74, 1991.
149. Kaklamani E, Trichopoulos D, Tzonou A, et al: Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265:1974-1976, 1991.
150. Simonetti RG, Camma C, Fiorello F, et al: Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116:97-102, 1992.
151. Bukh J, Miller RH, Kew MC, Purcell RH: Hepatitis C viras RNA in southern African Blacks with hepatocellular carcinoma. Proc Natl Acad Sci 90:1848-1851, 1993.